GE HealthCare Technologies Inc. $GEHC Shares Sold by Mizuho Markets Cayman LP

Mizuho Markets Cayman LP decreased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 96.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,566 shares of the company’s stock after selling 384,434 shares during the quarter. Mizuho Markets Cayman LP’s holdings in GE HealthCare Technologies were worth $1,169,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. lifted its stake in shares of GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after purchasing an additional 196 shares during the period. Godsey & Gibb Inc. purchased a new position in GE HealthCare Technologies in the third quarter valued at $26,000. Oakworth Capital Inc. raised its position in shares of GE HealthCare Technologies by 1,876.2% in the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock worth $31,000 after acquiring an additional 394 shares during the period. Piscataqua Savings Bank raised its position in shares of GE HealthCare Technologies by 173.4% in the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after acquiring an additional 300 shares during the period. Finally, Salomon & Ludwin LLC boosted its stake in shares of GE HealthCare Technologies by 326.5% during the 3rd quarter. Salomon & Ludwin LLC now owns 482 shares of the company’s stock worth $37,000 after acquiring an additional 369 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Up 2.0%

GEHC stock opened at $72.17 on Tuesday. The stock has a market capitalization of $32.89 billion, a P/E ratio of 15.83, a P/E/G ratio of 1.56 and a beta of 1.03. The firm has a 50-day simple moving average of $80.53 and a 200-day simple moving average of $78.53. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. During the same period last year, the company posted $1.45 EPS. GE HealthCare Technologies’s quarterly revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

Wall Street Analysts Forecast Growth

GEHC has been the topic of a number of analyst reports. Citigroup dropped their target price on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 11th. Evercore increased their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Wall Street Zen raised GE HealthCare Technologies from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. Jefferies Financial Group boosted their price objective on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Finally, Wells Fargo & Company upped their target price on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $92.17.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.